Beam Therapeutics Inc
(BEAM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -189,720 | -98,669 | -132,527 | -275,324 | -179,236 |
| Depreciation Amortization | -1,495 | -1,145 | -9,731 | -7,739 | -5,042 |
| Accounts payable and accrued liabilities | 3,057 | 1,285 | -7,578 | -5,810 | -2,765 |
| Other Working Capital | -61,719 | -32,700 | -114,436 | -87,228 | -65,175 |
| Other Operating Activity | 67,121 | 31,482 | 115,077 | 91,833 | 57,734 |
| Operating Cash Flow | $-182,756 | $-99,747 | $-149,195 | $-284,268 | $-194,484 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,399 | -2,438 | -33,732 | -30,143 | -22,195 |
| Purchase Of Investment | -329,714 | -195,241 | -984,338 | -931,066 | -657,359 |
| Sale Of Investment | 368,142 | 144,215 | 1,089,910 | 934,950 | 663,525 |
| Investing Cash Flow | $34,029 | $-53,464 | $71,840 | $-26,259 | $-16,029 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,314 | 3,074 | 279,331 | 244,986 | 207,425 |
| Other Financing Activity | -284 | -177 | -2,883 | -2,251 | -1,467 |
| Financing Cash Flow | $3,030 | $2,897 | $276,448 | $242,735 | $205,958 |
| Beginning Cash Position | 444,614 | 444,614 | 245,521 | 245,521 | 245,521 |
| End Cash Position | 298,917 | 294,300 | 444,614 | 177,729 | 240,966 |
| Net Cash Flow | $-145,697 | $-150,314 | $199,093 | $-67,792 | $-4,555 |
| Free Cash Flow | |||||
| Operating Cash Flow | -182,756 | -99,747 | -149,195 | -284,268 | -194,484 |
| Capital Expenditure | -4,399 | -2,438 | -33,732 | -30,143 | -22,195 |
| Free Cash Flow | -187,155 | -102,185 | -182,927 | -314,411 | -216,679 |